111 – 120 of 295
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Pridopidine Induces Functional Neurorestoration Via the Sigma-1 Receptor in a Mouse Model of Parkinson’s Disease
(
- Contribution to journal › Article
-
Mark
In vitro methods to study colon release : State of the art and an outlook on new strategies for better in-vitro biorelevant release media
(
- Contribution to journal › Scientific review
-
Mark
Antiparasitic metabolites from hyptis brevipes, a tacana medicinal plant
(
- Contribution to journal › Article
-
Mark
Exploration of purinergic receptors as potential anti-migraine targets using established pre-clinical migraine models
(
- Contribution to journal › Article
-
Mark
Long-Term, Targeted Delivery of GDNF from Encapsulated Cells Is Neuroprotective and Reduces Seizures in the Pilocarpine Model of Epilepsy
2019) In The Journal of Neuroscience : the official journal of the Society for Neuroscience 39(11). p.2144-2156(
- Contribution to journal › Article
-
Mark
In Vivo Silencing of MicroRNA-132 Reduces Blood Glucose and Improves Insulin Secretion
(
- Contribution to journal › Article
-
Mark
High-dose naloxone, an experimental tool uncovering latent sensitisation : pharmacokinetics in humans
(
- Contribution to journal › Article
-
Mark
The benefit of taxane-based therapies over fluoropyrimidine plus platinum (FP) in the treatment of esophageal cancer : a meta-analysis of clinical studies
(
- Contribution to journal › Article
-
Mark
Benefit–risk Assessment of Cladribine Using Multi-criteria Decision Analysis (MCDA) for Patients With Relapsing-remitting Multiple Sclerosis
(
- Contribution to journal › Article
-
Mark
‘Stealth’ corporate innovation : an emerging threat for therapeutic drug development
(
- Contribution to journal › Debate/Note/Editorial